Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

Brain changes in older adults at very low risk for Alzheimer's disease.

Fjell AM, McEvoy L, Holland D, Dale AM, Walhovd KB; Alzheimer's Disease Neuroimaging Initiative..

J Neurosci. 2013 May 8;33(19):8237-42. doi: 10.1523/JNEUROSCI.5506-12.2013.

2.

Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.

Susanto TA, Pua EP, Zhou J; Alzheimer’s Disease Neuroimaging Initiative..

J Alzheimers Dis. 2015;45(1):253-68. doi: 10.3233/JAD-142451.

PMID:
25524955
3.

The relation of regional cerebral perfusion and atrophy in mild cognitive impairment (MCI) and early Alzheimer's dementia.

Luckhaus C, Cohnen M, Flüss MO, Jänner M, Grass-Kapanke B, Teipel SJ, Grothe M, Hampel H, Peters O, Kornhuber J, Maier W, Supprian T, Gaebel W, Mödder U, Wittsack HJ.

Psychiatry Res. 2010 Jul 30;183(1):44-51. doi: 10.1016/j.pscychresns.2010.04.003. Epub 2010 Jun 11.

PMID:
20541374
4.
5.

Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study.

Ridha BH, Barnes J, Bartlett JW, Godbolt A, Pepple T, Rossor MN, Fox NC.

Lancet Neurol. 2006 Oct;5(10):828-34.

PMID:
16987729
6.

Apolipoprotein e4 affects topographical changes in hippocampal and cortical atrophy in Alzheimer's disease dementia: a five-year longitudinal study.

Kim YJ, Cho H, Kim YJ, Ki CS, Chung SJ, Ye BS, Kim HJ, Kim JH, Kim ST, Lee KH, Jeon S, Lee JM, Chin J, Kim JH, Na DL, Seong JK, Seo SW.

J Alzheimers Dis. 2015;44(4):1075-85. doi: 10.3233/JAD-141773.

PMID:
25391384
7.

Association of gray matter atrophy with age, β-amyloid, and cognition in aging.

Oh H, Madison C, Villeneuve S, Markley C, Jagust WJ.

Cereb Cortex. 2014 Jun;24(6):1609-18. doi: 10.1093/cercor/bht017. Epub 2013 Feb 6.

8.

Apolipoprotein E ε4 Modulates Cognitive Profiles, Hippocampal Volume, and Resting-State Functional Connectivity in Alzheimer's Disease.

Wang X, Wang J, He Y, Li H, Yuan H, Evans A, Yu X, He Y, Wang H.

J Alzheimers Dis. 2015;45(3):781-95. doi: 10.3233/JAD-142556.

PMID:
25624419
9.

Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease.

Honea RA, Swerdlow RH, Vidoni ED, Burns JM.

Neurology. 2011 Mar 1;76(9):822-9. doi: 10.1212/WNL.0b013e31820e7b74.

10.

Gray matter network associated with risk for Alzheimer's disease in young to middle-aged adults.

Alexander GE, Bergfield KL, Chen K, Reiman EM, Hanson KD, Lin L, Bandy D, Caselli RJ, Moeller JR.

Neurobiol Aging. 2012 Dec;33(12):2723-32. doi: 10.1016/j.neurobiolaging.2012.01.014. Epub 2012 Mar 8.

11.

Time course of brain volume changes in the preclinical phase of Alzheimer's disease.

Bernard C, Helmer C, Dilharreguy B, Amieva H, Auriacombe S, Dartigues JF, Allard M, Catheline G.

Alzheimers Dement. 2014 Mar;10(2):143-151.e1. doi: 10.1016/j.jalz.2013.08.279. Epub 2014 Jan 10.

PMID:
24418054
12.

Normative estimates of cross-sectional and longitudinal brain volume decline in aging and AD.

Fotenos AF, Snyder AZ, Girton LE, Morris JC, Buckner RL.

Neurology. 2005 Mar 22;64(6):1032-9.

PMID:
15781822
13.

Comparing new templates and atlas-based segmentations in the volumetric analysis of brain magnetic resonance images for diagnosing Alzheimer's disease.

Shen Q, Zhao W, Loewenstein DA, Potter E, Greig MT, Raj A, Barker W, Potter H, Duara R.

Alzheimers Dement. 2012 Sep;8(5):399-406. doi: 10.1016/j.jalz.2011.07.002.

PMID:
22959698
14.

Semantic memory activation in amnestic mild cognitive impairment.

Woodard JL, Seidenberg M, Nielson KA, Antuono P, Guidotti L, Durgerian S, Zhang Q, Lancaster M, Hantke N, Butts A, Rao SM.

Brain. 2009 Aug;132(Pt 8):2068-78. doi: 10.1093/brain/awp157. Epub 2009 Jun 10.

15.

Following the Spreading of Brain Structural Changes in Alzheimer's Disease: A Longitudinal, Multimodal MRI Study.

Weiler M, Agosta F, Canu E, Copetti M, Magnani G, Marcone A, Pagani E, Balthazar ML, Comi G, Falini A, Filippi M.

J Alzheimers Dis. 2015;47(4):995-1007. doi: 10.3233/JAD-150196.

PMID:
26401778
16.

Neuroimaging biomarkers for Alzheimer's disease in asymptomatic APOE4 carriers.

Chételat G, Fouquet M.

Rev Neurol (Paris). 2013 Oct;169(10):729-36. doi: 10.1016/j.neurol.2013.07.025. Epub 2013 Sep 6. Review.

17.

Precuneus atrophy in early-onset Alzheimer's disease: a morphometric structural MRI study.

Karas G, Scheltens P, Rombouts S, van Schijndel R, Klein M, Jones B, van der Flier W, Vrenken H, Barkhof F.

Neuroradiology. 2007 Dec;49(12):967-76. Epub 2007 Oct 23.

PMID:
17955233
18.

Segmentation and volumetric analysis of the caudate nucleus in Alzheimer's disease.

Jiji S, Smitha KA, Gupta AK, Pillai VP, Jayasree RS.

Eur J Radiol. 2013 Sep;82(9):1525-30. doi: 10.1016/j.ejrad.2013.03.012. Epub 2013 May 7.

PMID:
23664648
19.

Comparison of regional gray matter volume abnormalities in Alzheimer׳s disease and late life depression with hippocampal atrophy using VSRAD analysis: a voxel-based morphometry study.

Shimoda K, Kimura M, Yokota M, Okubo Y.

Psychiatry Res. 2015 Apr 30;232(1):71-5. doi: 10.1016/j.pscychresns.2015.01.018. Epub 2015 Jan 31.

20.

Evaluation of whole brain health in aging and Alzheimer's disease: a standard procedure for scoring an MRI-based brain atrophy and lesion index.

Guo H, Song X, Schmidt MH, Vandorpe R, Yang Z, LeBlanc E, Zhang J, Beyea S, Zhang Y, Rockwood K.

J Alzheimers Dis. 2014;42(2):691-703. doi: 10.3233/JAD-140333.

PMID:
24927702

Supplemental Content

Support Center